Neil B. Varshneya, PhD, MBA
Affiliations: | 2021- | Controlled Substance Staff | United States Food and Drug Administration, Silver Spring, MD, United States |
Area:
pharmacologyWebsite:
https://www.linkedin.com/in/neilvarshneya/Google:
"https://scholar.google.com/citations?user=F3xK-owAAAAJ&hl=en"Bio:
Senior Pharmacologist at United States Food and Drug Administration
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Patrick M. Beardsley | grad student | 2016-2020 | VCU School of Medicine |
| Kelly E. Dunn | post-doc | 2020-2021 | Johns Hopkins Medical School (PsychTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Varshneya NB, Hassanien SH, Holt MC, et al. (2023) Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression. Pharmacology, Biochemistry, and Behavior. 226: 173572 |
| Elder HJ, Varshneya NB, Walentiny DM, et al. (2022) Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner. Drug and Alcohol Dependence. 243: 109740 |
| Varshneya NB, Walentiny DM, Stevens DL, et al. (2022) Structurally diverse fentanyl analogs yield differential locomotor activities in mice. Pharmacology, Biochemistry, and Behavior. 173496 |
| Varshneya NB, Thakrar AP, Lambert E, et al. (2022) Opioid Use Disorder Treatment in the Fentanyl Era. Journal of Addiction Medicine. 17: 118-119 |
| Varshneya NB, Dunn KE, Grubb CJ, et al. (2022) Can initial experiences with drugs predict future drug abuse risks? Experimental and Clinical Psychopharmacology |
| Varshneya NB, Hassanien SH, Holt MC, et al. (2022) Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated. Biochemical Pharmacology. 195: 114805 |
| Jones JD, Varshneya NB, Hudzik TJ, et al. (2021) Improving Translational Research Outcomes for Opioid Use Disorder Treatments. Current Addiction Reports. 8: 109-121 |
| Varshneya NB, Thakrar AP, Hobelmann JG, et al. (2021) Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl. Journal of Addiction Medicine |
| Varshneya NB, Walentiny DM, Moisa LT, et al. (2021) Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors. Pharmacology, Biochemistry, and Behavior. 173242 |
| Nass SR, Hahn YK, McLane VD, et al. (2020) Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male mice. Brain, Behavior, & Immunity - Health. 5 |